Working… Menu

Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02638909
Recruitment Status : Terminated (Lack of Enrollment)
First Posted : December 23, 2015
Last Update Posted : April 2, 2018
University of Colorado, Denver
Information provided by (Responsible Party):
Criterium, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 29, 2018
Actual Study Completion Date : March 29, 2018